Revelation Biosciences Files Definitive Proxy Statement
Ticker: REVBW · Form: DEF 14A · Filed: Dec 16, 2024 · CIK: 1810560
| Field | Detail |
|---|---|
| Company | Revelation Biosciences, Inc. (REVBW) |
| Form Type | DEF 14A |
| Filed Date | Dec 16, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
Related Tickers: REV
TL;DR
REVB proxy filed. Shareholders vote soon.
AI Summary
Revelation Biosciences, Inc. filed a definitive proxy statement (DEF 14A) on December 16, 2024, for its fiscal year ending December 31, 2024. The company, formerly known as Petra Acquisition Inc. until April 23, 2020, is based in San Diego, CA, and operates in the pharmaceutical preparations industry. This filing is a standard procedural document related to shareholder voting and corporate governance.
Why It Matters
This filing is crucial for shareholders as it outlines important information regarding upcoming shareholder meetings, voting procedures, and corporate governance matters that could impact their investment.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial distress or significant corporate event.
Key Players & Entities
- REVELATION BIOSCIENCES, INC. (company) — Registrant
- Petra Acquisition Inc. (company) — Former company name
- 20241216 (date) — Filing date
- 20241213 (date) — Period of report
- 20200423 (date) — Date of name change
- 4660 LAJOLLA VILLAGE DRIVE (address) — Business and mailing address
- SAN DIEGO (location) — City
- DE (location) — State of incorporation
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is a document filed with the SEC by a company that is soliciting shareholder votes on specific matters, such as the election of directors or approval of corporate actions.
When was Revelation Biosciences, Inc. formerly known as?
Revelation Biosciences, Inc. was formerly known as Petra Acquisition Inc. until April 23, 2020.
What is the primary business of Revelation Biosciences, Inc.?
Revelation Biosciences, Inc. operates in the Pharmaceutical Preparations industry, with the SIC code 2834.
Where is Revelation Biosciences, Inc. located?
Revelation Biosciences, Inc. is located at 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122.
What is the fiscal year end for Revelation Biosciences, Inc.?
The fiscal year end for Revelation Biosciences, Inc. is December 31.
Filing Stats: 4,794 words · 19 min read · ~16 pages · Grade level 11.6 · Accepted 2024-12-16 08:54:41
Key Financial Figures
- $10,000 — eed to pay the proxy solicitor a fee of $10,000, plus disbursements. Revelation will re
Filing Documents
- revb-20241213.htm (DEF 14A) — 869KB
- img40523505_0.jpg (GRAPHIC) — 195KB
- img40523505_1.jpg (GRAPHIC) — 173KB
- 0000950170-24-136402.txt ( ) — 1378KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 29 OTHER MATTERS 31 HOUSEHOLDING 32 DEFINITIVE PROXY STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS TO BE HELD JANUARY 17, 2025 FIRST MAILED ON OR ABOUT DECEMBER 16, 2024 Date, Time and Place of the Special Meeting The enclosed proxy is solicited by the Board of Directors (the “ Board ”) of Revelation Biosciences, Inc., a Delaware corporation (“ the Company ,” “ Revelation ” or “ we ”), in connection with the Special Meeting of Stockholders (the “ Special Meeting ”) to be held at 12:00 p.m. Eastern Time on January 17, 2025 for the purposes set forth in the accompanying Notice of Special Meeting. The Special Meeting will be a virtual meeting only and will be held via a Zoom videoconference. Stockholders will not be able to physically attend the meeting. The virtual meeting can be accessed by using the following link: https://revbproxy.com/special-meeting-1%2F17%2F2025-1 . Any stockholder who is unable to join the online meeting can participate by telephone by dialing (929) 205-6099, and using the Zoom Meeting ID 818 7130 5249 and the Passcode 614116. The principal executive office of the Company is 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122, and its telephone number, including area code, is (650) 800-3717. QUESTIONS AND ANSWERS ABOUT THIS PROXY STATEMENT AND VOTING What is a proxy? A proxy is the legal designation of another person to vote the stock you own. That other person is called a proxy. If you designate someone as your proxy in a written document, that document is also called a proxy or a proxy card. By completing, signing and returning the accompanying proxy card, you are designating James Rolke, Chief Executive Officer, and Chester S. Zygmont, III, Chief Financial Officer, as your proxies for the Special Meeting and you are authorizing Messrs. Rolke and Zygmont to vote your shares at t